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Abstract
Background—In April 2009, a pandemic caused by a novel influenza strain, the
A(H1N1)pdm09 virus, started. Few age-specific estimates of hospitalizations associated with the
first year of circulation of the pandemic virus are available.
Objectives—To estimate age-specific hospitalization rates associated with laboratory-confirmed
A(H1N1)pdm09 virus in Davidson County, TN, from May 2009 to March 2010.
Patients/methods—Two separate strategies were applied: capture–recapture and surveillance-
sampling methods. For the capture–recapture estimates, we linked data collected via two
independent prospective population-based surveillance systems: The Influenza Vaccine
Effectiveness Network (Flu-VE) tested consenting county patients hospitalized with respiratory
symptoms at selected hospitals using real-time reverse transcriptase polymerase chain reaction
(rRT-PCR); the Emerging Infections Program identified county patients with positive influenza
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tests in all area hospitals. For the surveillance-sampling estimates, we applied the agespecific
proportions of influenza-positive patients (from Flu-VE) to the number of acute respiratory illness
hospitalizations obtained from the Tennessee Hospital Discharge Data system.
Results—With capture–recapture, we estimated 0.89 (95% CI, 0.72–1.49), 0.62 (0.42–1.11),
1.78 (0.99–3.63), and 0.76 (0.50–1.76) hospitalizations per 1000 residents aged <5, 5–17, 18–49,
and ≥50 years, respectively. Surveillance-sampling estimated rates were 0.78 (0.46–1.22), 0.32
(0.14–0.69), 0.99 (0.64–1.52), and 1.43 (0.80–2.48) hospitalizations per 1000 residents aged <5,
5–17, 18–49, and ≥50 years, respectively. In all age-groups combined, we estimated
approximately 1 influenza-related hospitalization per 1000 residents.
Conclusions—Two independent methods provided consistent results on the burden of pandemic
virus in Davidson County and suggested that the overall incidence of A(H1N1)pdm09-associated
hospitalization was 1 per 1000 county residents.
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Introduction
A novel influenza strain, the A(H1N1)pdm09 virus, was first recognized in April 2009
leading to a pandemic that affected more than 40 million people and caused about 13 000
deaths in the United States alone.1–4 However, few data are available on the age-specific
hospitalization rates of laboratory-confirmed disease caused by the A(H1N1)pdm09 virus.
Although complete enumeration of all influenza hospitalizations would be ideal, this would
be labor-intensive, expensive, and only feasible in small populations. We used data available
from surveillance systems and administrative databases to estimate hospitalization rates
associated with A(H1N1)pdm09 virus in Davidson County, TN, USA, using two methods:
(i) the capture–recapture analysis linked data from two independent systems, the Influenza
Vaccine Effectiveness Network (Flu-VE) and the Emerging Infections Programs (EIP), and
(ii) the surveillance-sampling method combined data from Flu-VE and the TN State
Hospital Discharge Data System (HDDS).
Methods
Population and setting
Davidson County, TN, had 635 710 residents in 2009 with similar age and gender
distribution to that of the United States with the exception of a higher percentage of Black
people (27.3% versus 13.6%) and a lower percentage of Hispanics (9.0% versus 15.8%)5.
Sources of data
The Davidson County population was under annual surveillance for influenza by two active
independent systems both funded by the Centers for Disease Control and Prevention (CDC):
Flu-VE and EIP. In addition, all hospital discharge data in the state of TN, including
admission and discharge dates and coded discharge diagnoses, and county of residence, are
available from the HDDS.
Influenza Vaccine Effectiveness Network (Flu-VE)
The Flu-VE operated in 4 US communities including Davidson County, TN, and performed
active populationbased influenza surveillance in children and adults presenting with acute
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respiratory illnesses (ARI) to area hospitals and emergency departments to ascertain
laboratory-confirmed influenza and to estimate annual influenza vaccine effectiveness.
During the first year of circulation of A(H1N1)pdm09 virus in Davidson County (from May
2009 to April 2010), the Flu-VE enrolled patients 5 days a week in four adult hospitals that
encompassed nearly 60% of county ARI admissions for adults. For children, Flu-VE
surveillance began in October 2009 and included the single large children’s hospital that
historically admitted about 95% of all ARI admissions in the county. Surveillance data from
May through September 2009 for children aged <5 years were provided by the New Vaccine
Surveillance Network (NVSN) that had applied the same surveillance protocol as Flu-VE.
However, there was no comparable surveillance for children aged 5–17 years during these
months.
Flu-VE enrolled Davidson County residents presenting with respiratory symptoms or with
fever without other known non-respiratory causes. Patients were approached within 48 hours
of admission to assess eligibility and obtain informed consent for participation. Chronic
medical conditions associated with influenza complications as defined per the Advisory
Committee on Immunization Practices recommendations7 were obtained through a
standardized questionnaire and chart review.
Nasal and throat swabs were collected and transported in viral transport media to the
Vanderbilt research laboratory within 2–3 hours of collection and kept at 4°C. Specimens
were aliquoted into lysis buffer and stored at −80°C. Realtime reverse transcriptase
polymerase chain reaction (rRTPCR) was performed for influenza virus identification and
influenza A subtyping using CDC-provided primers and probes according to the CDC
protocol 8. A sample was considered positive for influenza A virus if positive on two
separate runs. Subtyping was performed for seasonal H1N1 and H3N2, and A(H1N1)pdm09
viruses. Research laboratory results were not recorded in the participant’s medical record.
The Emerging Infections Program (EIP)
The EIP is also a population-based surveillance network conducted by state and local health
departments and academic health centers. Emerging Infections Program operates in 10 US
states for influenza surveillance and describes clinical aspects of laboratory-confirmed
influenza hospitalizations, describes risk factors for severe disease, and provides estimates
of age-specific influenza hospitalization rates based on clinical laboratory testing.9,10
During the 2009 A(H1N1)pdm09 pandemic, EIP performed active case finding at 20
hospitals located in Davidson and surrounding counties by reviewing the hospital laboratory
lists and infection control practitioner logs for clinical laboratory–positive influenza cases.
Patients were considered eligible if they were surveillance area residents and had a positive
result from an influenza test ordered by their healthcare provider. Trained surveillance
officers reviewed medical charts of all eligible patients to obtain demographic and clinical
characteristics.1,3,10,11 Testing for influenza and the type of clinical laboratory testing
performed were at the discretion of the provider. We considered as A(H1N1)pdm09
infection any influenza-positive test result from EIP because once the TN State laboratory
started performing PCR testing for A(H1N1)pdm09, seasonal A, and seasonal B in the first
week of September 2009, 99.4% of all specimens tested were A(H1N1)pdm09.2
State Hospital Discharge Data System (HDDS)
The HDDS is a large electronic resource of all hospital-based encounters (hospital and
emergency department discharges) in the state of Tennessee. This information is collected
by state mandate and it includes county of residence, date of birth, admission hospital, date
of admission and discharge, and discharge diagnoses.12
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Protection of human subjects
Flu-VE and NVSN protocols were approved by the institutional review boards (IRB) of all
participating hospitals. Influenza surveillance conducted through the EIP was considered a
public health response, and thus, it was declared exempt from review by the Vanderbilt
University, CDC, and the Tennessee Department of Health IRBs.
Statistical analysis
Capture–recapture estimates—Capture–recapture methods combine two or more
sources of data to estimate the size of a closed population. The number of cases identified by
each source and the number of matched cases common to both sources are used to estimate
the total number of cases in the study population assuming independence between the data
sources.13–17
We used data from Flu-VE and EIP to estimate the number of A(H1N1)pdm09-hospitalized
patients applying capture–recapture. Patients with influenza-related hospitalizations
identified by both surveillance systems were defined as matched cases. To identify matched
cases, we used patient’s name, date of birth, date, and place of hospitalization. After
matching, all data were de-identified for analyses.
As influenza-related hospitalizations were rare events, we applied the capture–recapture
nearly unbiased estimator correction, an analytical strategy that performs well with sparse
events.16,17 The calculation of total A(H1N1)pdm09-associated hospitalizations in the
surveillance hospitals (N) required the number of A(H1N1)pdm09-associated
hospitalizations that were detected by both systems or ‘matched’ (a), by Flu-VE only (b),
and by EIP only (c). Thus, N = a+b+c+y, where y = bc/(a+1), the estimated number of
A(H1N1)pdm09-associated hospitalizations missed by both surveillance systems.16
Except for children aged <5 years, for whom there was complete surveillance, the capture–
recapture estimates were weighted to account for incomplete surveillance for the three other
age-groups and the overall population. For patients aged 5–17 years for whom surveillance
began in October, we assumed the same distribution of cases as reported for children aged
<5 years from October 2009 to March 2010. Based on the observed distribution of
laboratory-confirmed influenza hospitalizations in children aged <5 years, we assumed that
A(H1N1)pdm09-associated hospitalizations detected from October through March in
patients aged 5–17 years represented 31% of A(H1N1)pdm09 admissions for the entire
period. To adjust our estimates for this incomplete surveillance, we divided the number of
cases ‘captured’ by Flu-VE only, by EIP only, and by both Flu-VE and EIP by 0.31 prior to
doing the capture–recapture calculation. For adults, for whom surveillance hospitals
represented a subset of the total Davidson County hospitals, based on the HDDS data, we
calculated the proportion of Davidson County residents with acute respiratory infections
being admitted at the four surveillance hospitals. We adjusted the capture–recapture
estimates similar to that described above for 5- to 17-year-olds.
Confidence intervals around the capture–recapture estimates were calculated by
bootstrapping with 1000 samples18 adjusted for incomplete surveillance for age-groups 5–
17, 18–49, ≥50 years, and the overall population. We reported the bias-corrected
bootstrapped intervals19 for all age-groups.
Age-specific influenza-associated hospitalization rates were defined as the estimated number
of influenza-related hospitalizations divided by Davidson County population estimates from
the US Census July 2009 estimates.5
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Surveillance-sampling estimates—The surveillance-sampling method used data from
the Flu-VE study and HDDS. The number of influenza-related hospitalizations was
calculated by multiplying the proportion of influenza virus positives among tested samples
from FluVE by the total number of ARI hospitalizations identified from HDDS. Based on
the clinical characteristics of A(H1N1)pdm09 virus infection and published data on
previously used codes, we defined as potential ARI-related hospitalizations those in which
the discharge diagnoses included one of the following ICD-9-CM codes 381–382 (otitis
media), 460–466 (upper respiratory infections), 480–487 (pneumonia and influenza), 490–
493 (bronchitis, emphysema, asthma), 786 (dyspnea and respiratory abnormalities), and
780.6 (fever).20–22 The code specific to the A(H1N1)pdm09 infection (488.1) was added in
October 2009, was rarely used, and was not included.
Age-specific influenza-related hospitalization rates were calculated by dividing the
estimated number of influenzarelated hospitalizations by Davidson County population
estimates.5 As there was complete enumeration of discharged patients from HDDS and the
county population from the Census, the main source of variability was the proportion of
influenza tests positive from the Flu-VE study. We calculated the 95% CI of this proportion
using the Wilson method for binomial distributions and applied the upper and lower bounds
to the number of ARI admissions in county residents captured by HDDS to obtain 95% CI
of the weighted number of influenza-related hospitalizations in county residents.
We computed 95% CI around the rates for both methods by dividing the upper- and lower-
bound weighted number by the county population from the Census. Data concerning clinical
characteristics were restricted to patients enrolled in Flu-VE. Pearson’s chi-square or
Fisher’s exact tests were used for contingency tables when appropriate. Data analyses were
performed using R version 2.12.2 and stata version 10.0.
Results
Flu-VE identified 2221 eligible patients admitted with respiratory symptoms and
approached 1975 patients (89.0%); those not approached included 125 patients discharged
before enrollment was possible (50.8%) and 121 patients missed (49.2%). From the 1975
patients approached, Flu-VE enrolled 1181 (60.0%) including 420 (35.6%), 83 (7.0%), 227
(19.2%), and 451 (38.2%) patients aged <5, 5–17, 18–49, and ≥50 years, respectively.
Among patients approached but not enrolled, refusal was lower in children (121/ 227,
53.3%, as compared to adults, 459/567, 81.0%). Forty-four enrolled patients had a specimen
that tested positive for influenza A, negative for seasonal influenza, and positive for
A(H1N1)pdm09 on two separate runs. Six patients had a specimen positive for influenza A,
negative for seasonal influenza A and positive for only one A(H1N1)pdm09 subtyping
assay, and one specimen was persistently positive for influenza A but negative for all
subtypes tested. Thus, Flu-VE surveillance identified 51 (4.3%) A(H1N1)pdm09-associated
hospitalizations.
Clinical characteristics
Compared with enrolled patients who tested negative, A(H1N1)pdm09-hospitalized patients
were more likely to be female (64.7% versus 47.0%), aged 18–49 (35.3% versus 18.5%),
and present with cough and/or fever/ feverishness (100% versus 91.6%). Sixty-four percent
of the 51 patients had at least one chronic medical condition including asthma, diabetes
mellitus, and kidney diseases, which was similar in influenza-negative patients. Compared
with influenza-negative patients who had an chest radiograph interpreted, A(H1N1)pdm09-
hospitalized patients were more likely to have a chest radiograph interpreted as pneumonia
(28.9% versus 21.9%), and to be prescribed antiviral medication (29.4% versus 3.9%), but a
similar percent required supplemental oxygen during their hospital stay (53.9% versus
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53.2%). Of note, 9/22 (40%) patients clinically diagnosed with A(H1N1)pdm09 infection
were prescribed antiviral medication. A(H1N1)pdm09-hospitalized patients were less likely
to be admitted to critical care (5.9% versus 12%); however, this difference was not
statistically significant. Of note, around 50% of enrolled patients who tested negative
admitted to ICU were in the two extreme age-groups (<1 year, 26%, and 65 years or more,
22.2%). In-hospital case fatality was 3.9% for A(H1N1)pdm09-hospitalized patients and
0.8% for influenza-negative patients (Table 1). The two influenza deaths were in adults aged
18–49 and ≥50 years.
Laboratory data
Forty of 51 A(H1N1)pdm09-hospitalized patients (78.4%) had an influenza test ordered as
part of their routine medical care, of which 22 (55%) had a positive result. From these 40
patients, 38 had a rapid test, primarily BinaxNOW Influenza A&B, of which 15 had a
positive result yielding a sensitivity of 39% (95% CI, 26–55%) for BinaxNOW Influenza
A&B using the research laboratory rRT-PCR as reference. The age-specific sensitivity of
BinaxNOW Influenza A&B to detect A(H1N1)pdm09 viral antigen was estimated to be
75%, 67%, 20%, and 13% in patients aged <5, 5–17, 18–49, and ≥50 years, respectively. Of
the 365 influenzanegative patients enrolled through Flu-VE who had a rapid test as the
unique clinical test performed, 358 had negative results, yielding a specificity of 98% (95%
CI, 96–99%) for BinaxNOW Influenza A&B compared to the research laboratory result.
Capture–recapture estimates
During the same time period that Flu-VE identified 51 A(H1N1)pdm09 admissions in
county residents at Flu-VE surveillance hospitals, EIP surveillance identified 126
A(H1N1)pdm09 admissions in county residents.
Flu-VE and EIP identified, respectively, 16 and 22 A(H1N1)pdm09-positive patients aged
<5 years, including eight children captured in both surveillance systems (matched), and five
and four positive patients aged 5–17 years, with one matched. Among adults, in the four
surveillance hospitals, Flu-VE and EIP identified, respectively, 18 and 43 A(H1N1)pdm09-
hospitalized patients aged 18–49 years (two matched), and 12 and 21 positive patients aged
≥50 years (three matched).
Estimated rates from capture–recapture analysis were 0.89 (95% CI, 0.72–1Æ49), 0.62 (0.
42–1.11), 1. 78 (0.99–3.63), and 0.76 (0.50–1.76) influenza-related hospitalizations per 1000
residents aged <5, 5–17, 18–49 and ≥50 years, respectively (Table 2). The overall
population estimate was 0.92 (0.71–1.43) influenza-related hospitalizations per 1000
Davidson County residents (Figure 1).
Reasons for the undetected influenza-related hospitalizations by Flu-VE included not being
approached by the surveillance staff (39.4%), admission on non-surveillance days (34.2%),
refused testing (15.8%), tested falsely negative (5.3%), or admission to non-surveillance
hospitals (5.3%). Reasons for the undetected hospitalizations for EIP included not tested
(35.2%), tested falsely negative (32.4%), and missed (32.4%). Of note, Flu-VE identified all
cases using rRT-PCR, whereas for EIP, influenza-related hospitalized patients had a rapid
test alone (53.0%), rRT-PCR and rapid test (28.0%), rRT-PCR only (11.0%), or other tests
(8%).
Surveillance-sampling estimates
From May to August 2009 (first wave), 0.9–4.4% of patients hospitalized with respiratory
symptoms were infected with the pandemic influenza virus. From September 2009 through
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March 2010 (second wave), influenzapositive proportion ranged from 3.0 to 8.8% (Figure
2).
The proportions of A(H1N1)pdm09-associated hospitalizations detected through Flu-VE
from May 2009 to March 2010 were 3.8%, 6.0%, 7.9%, and 2.7% for patients aged <5, 5–
17, 18–49, and≥50 years, respectively. We applied these age-specific proportions to the
ARI-estimated counts from HDDS and estimated 37 (95% CI, 22–83), 30 (13–65), 314
(202–483), and 253 (142–437) A(H1N1)pdm09-associated hospitalizations in Davidson
County residents aged <5, 5–17, 18–49, and ≥50 years, respectively (Table 2).
Surveillance-sampling rate estimates were 0.78 (95% CI, 0.46–1.22), 0.32 (0.14–0.69), 0.99
(0.64–1.52), and 1.43 (0.80–2Æ48) influenza-related hospitalizations per 1000 county
residents aged <5, 5–17, 18–49, and ≥50 years, respectively (Figure 1). The overall rate
estimated through the surveillance-sampling method was 1.00 (0.60–1.64) hospitalization
per 1000 Davidson County residents.
The first wave comprised only 17% of all pandemic influenza-associated hospitalizations
during the study period including 8%, 13%, 19%, and 15% of hospitalizations for residents
aged <5, 5–17, 18–49, and ≥50 years, respectively.
Ninety-eight percent of A(H1N1)pdm09-positive patients and 80.3% of A(H1N1)pdm09-
negative patients detected through Flu-VE had at least one of the ICD-9-CM discharge
codes used in the study to identify ARI hospitalizations in the HDDS. Among patients
counted as A(H1N1)pdm09 positive, the most common discharge diagnoses were
pneumonia and asthma. Only one Davidson County patient had a discharge diagnosis of
A(H1N1)pdm09 infection (488.1) (Table 3).
Discussion
We applied two different methods to estimate age-specific rates of A(H1N1)pdm09-
associated hospitalization in Davidson County, TN. Although estimates were higher from
capture–recapture in adults aged 18–49 and from surveillance-sampling in those aged ≥50
years, the confidence intervals overlapped and both methods yielded an overall rate of
approximately 1 hospitalization per 1000 residents.
Our results are consistent with those obtained from a CDC probabilistic multiplier model4,23
developed to account for underreporting of influenza-related hospitalizations in the United
States during the pandemic (H1N1) 2009. This CDC model recognized that only a fraction
of influenza-related hospitalizations were reported through EIP surveillance during the
pandemic period because of multiple factors and attempted to correct the reported number of
laboratory-confirmed hospitalizations for several factors. These factors included the
proportion of patients with specimens collected, the proportion of specimens submitted for
confirmation, and the sensitivity of laboratory tests for detection of A(H1N1)pdm09 virus.
The rates of laboratory-confirmed influenza-related hospitalizations from the 10 EIP
surveillance states were extrapolated to the 50 US states taking into account regional
variation in influenza activity. The CDC model estimated 274 304 (195 086–402 719)
influenza-related hospitalizations for an overall estimated rate of 0.90 (95% CI, 0.64–1.32)
hospitalization per 1000 US residents (April 2009–April 2010).23 The age-specific estimated
hospitalization rates were 1.17 (0.83–1.72), 0.83 (0.59–1.23), and 0.70 (0.50–1.03) per 1000
US residents aged <18, 18–64, and ≥65 years, respectively.4,23 Although the age-group
divisions differed from those used in our study, the estimates from this CDC model provided
age-specific rates and confidence intervals that overlapped the rates and the confidence
intervals estimated using two additional and complementary methods in our study. Of note,
the multiplier model relies on assumptions that need to be updated annually to correct for
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missed diagnoses, whereas our methods may be routinely applied where surveillance for
influenza is ongoing.
Two other North American studies relied on clinical testing and yielded lower rates than
those we report here, especially in older age-groups. Helferty et al.24 reported laboratory-
confirmed A(H1N1)pdm09 infection and derived estimates for Canada of 1.65, 0.84, 0.29,
0.17, 0.24, and 0.18 hospitalization per 1000 residents aged <1, 1–4, 5–19, 20–44, 45–64,
and ≥65. Kumar et al.25 used passive surveillance based on specimens submitted for
confirmation to the Midwest Respiratory Virus Program and reported A(H1N1)pdm09-
associated hospitalization rates of 0.49, 0.18, 0.13, 0.06, 0.06, and 0.03 per 1000 Milwaukee,
Wisconsin, residents aged respectively <5, 5–18, 19–24, 25–49, 50–64, and ≥65 years. Rates
reported from Europe were even lower,26,27 likely due to reliance on passive reporting
systems and underrecognition of or undertesting for influenza.
While the use of capture–recapture methods seeks to correct for missed cases, the validity of
estimates made with these methods relies on the fulfillment of several assumptions: a closed
population without significant migration in or out, valid tests (Flu-VE used the highly
sensitive and specific rRT-PCR; 92% of patients identified by EIP had a positive rapid test
with a specificity of 98% in the population studied as compared to the research laboratory
rRTPCR), and independence of the two surveillance systems. We applied the unbiased
estimator approach because of sparse data in some cells particularly for age-group 5–17; this
method gives more conservative estimates with less chance of overestimation.16
Applying the surveillance-sampling method that used the HDDS as a completely different
source of data strengthened the study because it yielded similar overall estimates to those
obtained from capture–recapture that used Flu-VE and EIP. The surveillance-sampling
method represents a valuable inexpensive option to estimate disease burden. However, it
relies on the accuracy of the sampling procedures assuming systematic sampling of the study
population to ensure representativeness of the general population under observation. In
addition, it assumes that the ARI hospitalizations identified in HDDS closely mirrored those
actually sampled.
Our study has a number of limitations. First, we identified a relatively small number of
influenza-associated hospitalizations captured in the two systems because they both missed
cases. Cases missed included those not approached by the recruiters in Flu-VE, and those
not tested, or tested falsely negative in EIP surveillance. In the Flu-VE study, we enrolled
only 1181/2221 (53.2%) eligible patients, raising the possibility of selection bias. Bias also
could have occurred particularly in our surveillance-sampling estimates leading to under- or
overestimation. This problem may have limited the precision of our incidence estimates as
reflected by the wide confidence intervals in our calculations. Second, we included in our
analysis seven patients who were identified as influenza A but did not meet formal CDC
criteria for A(H1N1)pdm09 virus detection. Inclusion of these patients would result in
overestimation if they rep- resented false positives. However, all these tests were
persistently influenza A positive, negative for seasonal H1N1 and H3N2, and 6 of the 7 were
positive for one of the two A(H1N1)pdm09-specific subtyping assays. These seven were
considered to be A(H1N1)pdm09 virus positives for this study, because no seasonal
influenza viruses were detected through surveillance during the study period. In addition, we
had incomplete surveillance for the age-group 5–17 years, because there was no inpatient
surveillance for this age-group before October 2009. An extrapolation method based on the
observed counts of influenza-related hospitalizations in children <5 years from May to
September 2009 was applied to estimate the total influenza-related hospitalizations in
children 5–17 years from May to September 2009.
Jules et al. Page 8
Influenza Other Respi Viruses. Author manuscript; available in PMC 2013 September 16.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
In adults, our sampling included hospitals that admitted only 60% of county patients with
ARI. However, the weighting procedure applied in both methods helped account for this
imprecision.
We also found a large difference between influenza-positive and influenza-negative patients
admitted to critical care (5.9% versus 12%); although not statistically significant, this
difference could be explained by the age distributions of two groups. Influenza-positive
patients were more likely to be 18–49 (35.3%), whereas influenza-negative patients were
more likely to be 50 years or more (38.8%).
Another critical point for the surveillance-sampling method is how well the diagnostic codes
used to identify ARI hospitalizations match the A(H1N1)pdm09 admissions identified
through Flu-VE. To identify eligible patients for enrollment in the Flu-VE, we used broad
screening criteria, which included any respiratory symptoms and/or fever without a non-
respiratory cause. To identify patients with ARI discharge diagnoses that were similar to our
target population, we used select ICD-9-CM codes and found that 98.0% of influenza-
positive and 80.3% of influenza-negative patients identified through surveillance had at least
one of these codes.
In summary, we estimated the rates of A(H1N1)pdm09-associated hospitalization in
Davidson County residents and found an overall rate of 1 per 1000 county residents using
distinctive capture–recapture and surveillance-sampling methods. In addition to providing
new data on the pandemic burden, these methods represent inexpensive and affordable tools
to estimate the completeness of case ascertainment as reported by two or more sources of
data. These methods can be readily applied whenever the related assumptions are fulfilled.
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Figure 1.
Estimated hospitalization rates associated with A(H1N1)pdm09 virus during the pandemic
(H1N1) 2009 estimated by capture–recapture and surveillance-sampling methods in
Davidson County residents aged <5, 5–17, 18–49, and ≥50 years.
Jules et al. Page 11
Influenza Other Respi Viruses. Author manuscript; available in PMC 2013 September 16.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2.
Proportion of hospitalized patients tested positive for A(H1N1)pdm09 during the pandemic
(H1N1) 2009 among the total Davidson County residents aged <5, 5–17, 18–49, ≥50 years
with symptoms of acute respiratory illnesses tested for A(H1N1)pdm09 through Flu-VE
from May 2009 to March 2010.
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Table 1
Characteristics of patients enrolled into Flu-VE study, Davidson Co, TN, from May 2009 to March 2010 by
influenza A(H1N1)pdm09 status
Characteristics
A(H1N1)pdm09
(+) n (%)
n = 51
A(H1N1)pdm09
(−) n (%)
n = 1130 P-value
Gender (female) 33 (64.7) 531 (47) 0.013
Age-group
  <5 years 16 (31.4) 404 (35.8)
  5–17 years 5 (9.8) 78 (6.9) 0.012
  18–49 years 18 (35.3) 209 (18.5)
  ≥50 years 12 (23.5) 439 (38.8)
Signs and symptoms
  Feverish 46 (90.2) 390 (61.1)
  Cough 3 (5.9) 312 (27.6) 0.012
  Fever 2 (3.9) 33 (2.9)
Most common conditions
  Asthma 26 (51.0) 489 (43.3) 0.117
  Diabetes mellitus 8 (15.7) 166 (14.7) 0.227
  Kidney disorder 4 (7.8) 53 (4.7) 0.490
  Other* 4 (7.8) 124 (7.8) 0.482
  Any of above 33 (64.7) 728 (64.4) 0.967
Any influenza test ordered 40 (78.4) 426 (37.7) <0.001
  Any negative result 18 (45.0) 415 (97.4) <0.001
  Any positive result 22 (55.0) 11 (2.6)
Chest X-ray report 38 (74.5) 789 (69.8) 0.475
  No acute abnormality 22 (57.9) 342 (43.4) 0.023
  Pneumonia 11 (28.9) 173 (21.9)
  Other acute abnormality 5 (13.2) 274 (34.7)
Admission to intensive care unit 3 (5.9) 135 (12.0) 0.186
Oxygen during hospital stay 27 (52.9) 601 (53.2) 0.955
Intubation 2 (3.9) 42 (3.7) 0.953
Died 2 (3.9) 9 (0.8) 0.067
*Other medical conditions included cardiovascular disease, HIV infections, and cancer. The percentage does not add to 100 because one patient
may have more than one underlying conditions.
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Table 3
Discharge diagnoses of patients enrolled in Flu-VE from May 2009 to March 2010 stratified by whether they
were included to calculate total respiratory admissions from hospital discharge data system (HDDS)
Any discharge
diagnoses
(ICD9-CM codes)
A(H1N1)pdm09 (+)
total = 51
n (%)
A(H1N1)pdm09 (−)
total = 1129*
n (%)
Discharge diagnoses included in current report 50 (98.0) 907 (80.3)
Pneumonia and influenza (480–487) 38 (76.0) 346 (38.1)
Bronchitis, emphysema, asthma (490–493) 9 (18.0) 307 (33.9)
Acute respiratory infections (460–466) 1 (2.0) 144 (15.9)
Dyspnea and respiratory abnormalities (786) 0 (0.0) 59 (6.5)
Fever (780.6) 2 (4.0) 48 (5.3)
Otitis media (381–382) 0 (0.0) 3 (0.3)
Discharge diagnoses not included 1 (2.0) 222 (19.7)
Pandemic (H1N1) 2009 (488) 0 (0.0) 1 (0.4)
Other respiratory (470–478, 494–519) 0 (0.0) 61 (27.5)
Circulatory (390–459) 0 (0.0) 53 (23.9)
Dehydration (276.51) 1 (100.0) 16 (7.2)
Other 0 (0.0) 91 (41.0)
*One missing discharge diagnosis.
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